• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

广泛性焦虑障碍的干预措施。

Interventions for generalized anxiety disorder.

作者信息

Byrne Gerard J

机构信息

Academy of Psychiatry, School of Medicine, University of Queensland.

Mental Health Service, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.

出版信息

Curr Opin Psychiatry. 2023 Mar 1;36(2):134-139. doi: 10.1097/YCO.0000000000000840. Epub 2022 Dec 6.

DOI:10.1097/YCO.0000000000000840
PMID:36705012
Abstract

PURPOSE OF REVIEW

To provide an overview of recently published work on anxiety, focusing on generalized anxiety disorder (GAD) and its treatment.

RECENT FINDINGS

Self-reported anxiety symptoms were highly prevalent during the COVID-19 global pandemic in both the general population and in selected groups. There remains divided opinion about whether internet-based cognitive behavioural therapy (CBT) is noninferior to face-to-face CBT for GAD. A systematic review of drug treatment for GAD showed efficacy for selective serotonin reuptake inhibitors (SNRIs), agomelatine, and quetiapine. There may be a place for repetitive transcranial magnetic stimulation in the treatment of GAD. There was some evidence of efficacy for complementary therapies, including physical exercise, yoga, acupuncture, and Withania somnifera (ashwagandha). However, a systematic review of cannabidiol and tetrahydrocannabinol found insufficient evidence of efficacy in anxiety disorders.

SUMMARY

Antidepressants and quetiapine show efficacy in the treatment of GAD. Internet-based psychological interventions have a place in the treatment of GAD when face-to-face treatment is inaccessible. There is increasing evidence for the use of physical exercise in the management of GAD. Some other complementary therapies, including cannabinoids, require further, methodologically sound, research.

摘要

综述目的

概述近期发表的关于焦虑症的研究工作,重点关注广泛性焦虑障碍(GAD)及其治疗。

最新发现

在新冠疫情全球大流行期间,普通人群和特定群体中自我报告的焦虑症状非常普遍。对于基于互联网的认知行为疗法(CBT)治疗GAD是否不劣于面对面CBT,仍存在分歧。一项关于GAD药物治疗的系统评价显示,选择性5-羟色胺再摄取抑制剂(SNRIs)、阿戈美拉汀和喹硫平有效。重复经颅磁刺激在GAD治疗中可能有一席之地。有一些证据表明补充疗法有效,包括体育锻炼、瑜伽、针灸和南非醉茄(印度人参)。然而,一项关于大麻二酚和四氢大麻酚的系统评价发现,在焦虑症治疗中疗效证据不足。

总结

抗抑郁药和喹硫平在GAD治疗中显示出疗效。当无法进行面对面治疗时,基于互联网的心理干预在GAD治疗中占有一席之地。越来越多的证据表明体育锻炼可用于管理GAD。其他一些补充疗法,包括大麻素,需要进一步开展方法严谨的研究。

相似文献

1
Interventions for generalized anxiety disorder.广泛性焦虑障碍的干预措施。
Curr Opin Psychiatry. 2023 Mar 1;36(2):134-139. doi: 10.1097/YCO.0000000000000840. Epub 2022 Dec 6.
2
Update on treatments for anxiety-related disorders.焦虑相关障碍的治疗进展
Curr Opin Psychiatry. 2023 Mar 1;36(2):140-145. doi: 10.1097/YCO.0000000000000841. Epub 2022 Dec 6.
3
Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines.一项随机对照试验的飞行员,该试验比较了选择性 5-羟色胺再摄取抑制剂舍曲林与认知行为疗法在广泛性焦虑障碍患者中的疗效,这些患者对国家卫生与保健卓越研究所指南定义的低强度心理治疗没有反应。
Health Technol Assess. 2017 Aug;21(45):1-138. doi: 10.3310/hta21450.
4
Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials.喹硫平单药治疗广泛性焦虑症的急性治疗:一项随机对照试验的系统评价和荟萃分析。
Drug Des Devel Ther. 2016 Jan 12;10:259-76. doi: 10.2147/DDDT.S89485. eCollection 2016.
5
Agomelatine in treating generalized anxiety disorder.阿戈美拉汀治疗广泛性焦虑障碍。
Expert Opin Investig Drugs. 2014 Jun;23(6):857-64. doi: 10.1517/13543784.2014.911840. Epub 2014 Apr 28.
6
New approaches to the pharmacological management of generalized anxiety disorder.广泛性焦虑障碍的药理学治疗新方法。
Expert Opin Pharmacother. 2013 Feb;14(2):175-84. doi: 10.1517/14656566.2013.759559. Epub 2013 Jan 3.
7
Efficacy of Yoga vs Cognitive Behavioral Therapy vs Stress Education for the Treatment of Generalized Anxiety Disorder: A Randomized Clinical Trial.瑜伽与认知行为疗法和应激教育治疗广泛性焦虑障碍的疗效比较:一项随机临床试验。
JAMA Psychiatry. 2021 Jan 1;78(1):13-20. doi: 10.1001/jamapsychiatry.2020.2496.
8
[Generalized anxiety disorder].[广泛性焦虑障碍]
Nervenarzt. 2014 Sep;85(9):1185-94. doi: 10.1007/s00115-014-4121-8.
9
WCA recommendations for the long-term treatment of generalized anxiety disorder.广泛性焦虑症长期治疗的世界华人医师协会建议。
CNS Spectr. 2003 Aug;8(8 Suppl 1):53-61. doi: 10.1017/s1092852900006945.
10
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.富马酸喹硫平缓释片(quetiapine XR)作为广泛性焦虑障碍且既往治疗反应不佳患者的辅助治疗:一项随机、双盲研究。
Ann Clin Psychiatry. 2013 Nov;25(4):E7-22.

引用本文的文献

1
Efficacy of electroacupuncture treatment for generalized anxiety disorder related insomnia: a study protocol for randomized controlled trial.电针治疗广泛性焦虑障碍相关失眠的疗效:一项随机对照试验的研究方案
Front Psychiatry. 2025 May 9;16:1532001. doi: 10.3389/fpsyt.2025.1532001. eCollection 2025.
2
Efficacy and exploratory analysis of potential mechanisms of stellate ganglion block in alleviating sleep disturbance in generalized anxiety disorder: a randomized controlled trial excluding comorbid depression.星状神经节阻滞缓解广泛性焦虑障碍睡眠障碍的疗效及潜在机制的探索性分析:一项排除共病抑郁的随机对照试验
Front Neurol. 2025 May 7;16:1554841. doi: 10.3389/fneur.2025.1554841. eCollection 2025.
3
The efficacy of acupuncture for generalized anxiety disorder (GAD) in college students: Study protocol for a randomized controlled trial.
针刺治疗大学生广泛性焦虑障碍的疗效:一项随机对照试验的研究方案
PLoS One. 2025 Jan 9;20(1):e0316804. doi: 10.1371/journal.pone.0316804. eCollection 2025.
4
Frontiers and hotspots in anxiety disorders: A bibliometric analysis from 2004 to 2024.焦虑症的前沿与热点:2004年至2024年的文献计量分析
Heliyon. 2024 Aug 5;10(16):e35701. doi: 10.1016/j.heliyon.2024.e35701. eCollection 2024 Aug 30.